Home / Sweden / Svolder Aktiebolag
Svolder Aktiebolag
SE0017161458 Short position disclosed on August 3, 2026.
0.79% of the capital sold short
1 disclosing funds
11 disclosures on record
Funds holding Svolder Aktiebolag Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
March 9, 2020 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Qube Research & Technologies Limited | 0.79% | new | August 3, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 3, 2026 | Qube Research & Technologies Limited | 0.79% | still open |
| July 29, 2026 | Qube Research & Technologies Limited | 0.80% | still open |
| July 8, 2026 | Qube Research & Technologies Limited | 0.70% | still open |
| July 1, 2026 | Qube Research & Technologies Limited | 0.69% | still open |
| July 1, 2026 | Millennium Capital (DIFC) Limited | 0.50% | still open |
| June 24, 2026 | Qube Research & Technologies Limited | 0.70% | still open |
| June 10, 2026 | Qube Research & Technologies Limited | 0.60% | still open |
| May 27, 2026 | Qube Research & Technologies Limited | 0.52% | still open |
| April 23, 2020 | Alcur Fonder AB | 0.00% | still open |
| April 20, 2020 | Alcur Fonder AB | 0.64% | still open |
| March 9, 2020 | Alcur Fonder AB | 0.52% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short